Wallis and Futuna - Press Releases

CHICAGO, March 5, 2025 /PRNewswire/ -- TheRobert Spadoni Scholarship for Entrepreneurs is now accepting applications from undergraduate students nationwide who demonstrate exceptional entrepreneurial potential. Established by healthcare executive Robert Spadoni, this $1,000 scholarship supports students committed to creating positive change through entrepreneurial ventures.

DURHAM, N.C., March 5, 2025 /PRNewswire/ --Pluto Health, a Duke-University spin-out, is now a qualified Medicaid provider in TN. The company integrates care delivery with its proprietary platform that leverages AI and data science to deliver convenient care options and health services for patients. This milestone strengthens Pluto Health's commitment to delivering comprehensive, accessible, and high-quality care to patients across the state, particularly those in underserved communities.

WASHINGTON, March 5, 2025 /PRNewswire/ --Paralyzed Veterans of AmericaChief Executive Officer Carl Blake releases statement following the leak of an internal memorevealing the Department of Veterans Affairs' plan to reduce its overall staffing of the department to FY 2019 levels - a decrease of more than 80,000 positions from the current staffing level.

With global cancer incidence rising and a strong clinical pipeline exploring combination therapies, the XPOVIO addressable market is expanding. Despite competition from CAR-T and novel therapies, XPOVIO's oral administration and unique mechanism offer differentiation.

The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and development of innovative interferon therapies are key factors fueling the expansion of the interferon market from 2025 to 2032.

SAN FRANCISCO, March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The rising prevalence of chronic illnesses such as diabetes, cardiovascular diseases, and cancer is greatly boosting the demand for biosensors, as these conditions necessitate frequent monitoring for proper management. Likewise, the increasing need for point-of-care testing (POCT) is propelling market growth, as biosensors offer fast and convenient diagnostic solutions beyond conventional healthcare facilities.

MINNEAPOLIS, March 5, 2025 /PRNewswire/ -- People who take over-the-counter pain relievers after a concussion may recover faster than those who do not take pain relievers, according to a preliminary study released March 5, 2025, that will be presented at the American Academy of Neurology's 77th Annual Meeting taking place April 5-9, 2025, in San Diego and online.

-Drugs found to be safe and effective overall despite some risk of eye damage

No Shareholder Action Required at this Time

SUZHOU, China, March 5, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Phase Ib clinical trial application in Australia for CS5001, its ROR1-targeting antibody-drug conjugate (ADC), in combination with first-line standard-of-care (SoC) for DLBCL. CS5001 is also being evaluated as both a monotherapy and in combination with a PD-L1 inhibitor for advanced solid tumors in an ongoing global multi-center clinical trial.

HONG KONG, March 5, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical trial (COMPASSION-22/AK104-306) evaluating cadonilimab, the world's first PD-1/CTLA-4 bispecific antibody independently developed by the company, as an adjuvant treatment for hepatocellular carcinoma (HCC) with high recurrence risk following curative resection or ablation.

- Joint venture will aim to develop a cell therapy manufacturing platform through robotics and will offer access to startups and academic institutions -

SCOTTSDALE, Ariz., March 5, 2025 /PRNewswire/ -- Axon (Nasdaq: AXON) ("Axon") announced today that it has priced $1,000.0 million aggregate principal amount of its Senior Notes due 2030 (the "2030 Notes") at an issue price of 100% and $750.0 million aggregate principal amount of its Senior Notes due 2033 at an issue price of 100% (the "2033 Notes" and, together with the 2030 Notes, the "Notes") in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The total offering size was increased from the previously announced total offering size of $1,500.0 million aggregate principal amount of Notes. Axon intends to use the net proceeds of this offering for general corporate purposes, which may include, among other things, potentially repurchasing or redeeming Axon's 0.50% Convertible Senior Notes due 2027 (the "Existing Convertible Notes"), and providing capital to support Axon's growth and to acquire or invest in product lines, products, services or technologies. The sale of the Notes is expected to close on March 11, 2025, subject to customary closing conditions.

CHATTANOOGA, Tenn., March 5, 2025 /PRNewswire/ -- Miller Industries, Inc. (NYSE: MLR) ("Miller Industries" or the "Company") today announced financial results for the fourth quarter and full year ended December 31, 2024.

CLEVELAND, March 5, 2025 /PRNewswire/ --

PEMBROKE, Bermuda, March 5, 2025 /PRNewswire/ -- Gold Reserve Ltd. (TSX.V: GRZ) (OTCQX: GDRZF) announced today that its wholly owned subsidiary, GR Mining (Barbados) Inc. (GR Mining), filed a request for arbitration against the Bolivarian Republic of Venezuela ("Venezuela") under the Additional Facility Rules of the International Centre for the Settlement of Investment Disputes of the World Bank in Washington, D.C.

HOUSTON, March 5, 2025 /PRNewswire/ --The Sterling Group ("Sterling"), a middle market private equity firm, announced today that it has completed the sale ofFrontline Road Safety ("Frontline" or the "Company") to Bain Capital. Frontline is the largest provider of pavement marking and ancillary services in the U.S. Financial terms of the private transaction were not disclosed.

Debuting on Saturday,Arden at Bedfordoffers exceptional new homes with open layouts

HARRISBURG, Pa., March 5, 2025 /PRNewswire/ -- As the spring thaw arrives, homeowners considering selling their property are encouraged to take advantage of warmer weather to enhance their home's appeal and marketability. According to the Pennsylvania Association of Realtors, spring home improvement projects can significantly impact the perceived value of a home and expedite the selling process.

BARCELONA, Spanien, 6. Mrz 2025 /PRNewswire/ -- Whrend des MWC Barcelona 2025 bringt Huawei Netzbetreiber, Industriepartner und Meinungsfhrer aus der ganzen Welt zusammen, um die berschneidung von 5G-Netzen und KI zu erforschen und zu untersuchen, wie sie sich gegenseitig untersttzen knnen, um neue Wachstumschancen zu erschlieen.

COURBEVOIE, France, March 5, 2025 /PRNewswire/ -- Global leader in payment and connectivity solutions IDEMIA Secure Transactions partners with Qualcomm Technologies to introduce a fully scalable and trusted iSIM solution to the IoT market. This involves delivering the world's first integrated and reprogrammable iSIM powered by the new Qualcomm E41 4G Modem-RF to help support compliance with the new IoT GSMA specification. Tailored for compact, power-efficient and cost-effective devices, this innovation is particularly appealing for sectors such as smart grid technologies, connected industry, healthcare and asset tracking.

NEW ROCHELLE, N.Y., March 5, 2025 /PRNewswire/ -- A new study, published in the peer-reviewed journal AI in Precision Oncology,examines the ability of large language models (LLMs) to rapidly extract PD-L1 biomarker details from the electronic health record (EHR).Click here to read the article now.

NEW YORK, March 5, 2025 /PRNewswire/ --Pokmon GO players looking for a reliable way to change location on iPhone. So now they can change their in-game location perfectly with newly released iToolab AnyGo Win V7.9.0. The latest 2025 update introduces Bluetooth Mode for iOS 17 and above, making location spoofing without a cracked version, safer and more convenient than ever.

A One-Day Immersive Experience Showcasing the Future of Seamless Travel with Cutting-Edge Technology, Exclusive Speaker Panels, and Interactive Engagements.